MOLINA HEALTHCARE, INC.
Business
Molina Healthcare, Inc. provides managed healthcare services to millions of members across multiple states under government-sponsored programs including Medicaid, Medicare, and Marketplace (ACA-compliant plans). The company offers health insurance products and medical management services such as care coordination, pharmacy benefits, and utilization management to low-income populations and seniors. Molina operates four reportable segments—Medicaid (the largest revenue contributor), Medicare, Marketplace, and Other—competing on provider network quality, state procurement success, and cost-effective care delivery.
Summary from 10-K filed 2026-02-10
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Premium revenue | 43,052 | 38,627 | 32,529 | 30,883 | 26,855 | |
| Premium tax revenue | 1,863 | 1,486 | 1,069 | 873 | 787 | |
| Investment income | 420 | 452 | 394 | 143 | 52 | |
| Other revenue | 91 | 85 | 80 | 75 | 77 | |
| Total revenue | 45,426 | 40,650 | 34,072 | 31,974 | 27,771 | |
| Medical care costs | 39,488 | 34,428 | 28,669 | 27,175 | 23,704 | |
| General and administrative expenses | 3,009 | 2,743 | 2,462 | 2,311 | 2,068 | |
| Premium tax expenses | 1,863 | 1,486 | 1,069 | 873 | 787 | |
| Depreciation and amortization | 195 | 186 | 171 | 176 | 131 | |
| Other | 90 | 100 | 128 | 58 | 61 | |
| Total operating expenses | 44,645 | 38,943 | 32,499 | 30,801 | 26,751 | |
| Operating income | 781 | 1,707 | 1,573 | 1,173 | 1,020 | |
| Interest expense | 192 | 118 | 109 | 110 | — | |
| Income before income tax expense | 589 | 1,589 | 1,464 | 1,063 | 875 | |
| Income tax expense | 117 | 410 | 373 | 271 | 216 | |
| Net income | 472 | 1,179 | 1,091 | 792 | 659 | |
| Basic (in dollars per share) | 8.93 | 20.52 | 18.91 | 13.72 | 11.4 | |
| Diluted (in dollars per share) | 8.92 | 20.42 | 18.77 | 13.55 | 11.25 | |
| Basic (in shares) | 53 | 57 | 58 | 58 | 58 | |
| Diluted (in shares) | 53 | 58 | 58 | 59 | 59 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 4,248 | 4,662 | 4,848 | 4,006 | 4,438 | |
| Investments | 4,008 | 4,325 | 4,259 | 3,499 | 3,202 | |
| Receivables | 3,533 | 3,299 | 3,104 | 2,302 | 2,177 | |
| Prepaid expenses and other current assets | 655 | 487 | 331 | 277 | 247 | |
| Total current assets | 12,444 | 12,773 | 12,542 | 10,084 | 10,064 | |
| Property, equipment, and capitalized software, net | 301 | 288 | 270 | 259 | 396 | |
| Goodwill and intangible assets, net | 2,195 | 1,938 | 1,449 | 1,390 | 1,252 | |
| Restricted investments | 299 | 286 | 261 | 238 | 212 | |
| Deferred income taxes, net | 178 | 207 | 227 | 220 | 106 | |
| Other assets | 147 | 138 | 143 | 123 | 179 | |
| Total assets | 15,564 | 15,630 | 14,892 | 12,314 | 12,209 | |
| Medical claims and benefits payable | 4,887 | 4,640 | 4,204 | 3,528 | 3,363 | |
| Amounts due government agencies | 1,326 | 1,874 | 2,294 | 2,079 | 2,472 | |
| Accounts payable, accrued liabilities and other | 1,093 | 1,331 | 1,252 | 889 | 842 | |
| Deferred revenue | 66 | 51 | 418 | 359 | 370 | |
| Total current liabilities | 7,372 | 7,896 | 8,168 | 6,855 | 7,047 | |
| Long-term debt | 3,766 | 2,923 | 2,180 | 2,176 | 2,173 | |
| Finance lease liabilities | 184 | 195 | 205 | 215 | 219 | |
| Other long-term liabilities | 173 | 120 | 124 | 104 | 140 | |
| Total liabilities | 11,495 | 11,134 | 10,677 | 9,350 | 9,579 | |
| Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 51 million shares at December 31, 2025, and 56 million at December 31, 2024 | 0 | 0 | 0 | 0 | 0 | |
| Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding | 0 | 0 | 0 | 0 | 0 | |
| Additional paid-in capital | 452 | 462 | 410 | 328 | 236 | |
| Accumulated other comprehensive income (loss) | 15 | −57 | −82 | −160 | −5 | |
| Retained earnings | 3,602 | 4,091 | 3,887 | 2,796 | 2,399 | |
| Total stockholders equity | 4,069 | 4,496 | 4,215 | 2,964 | 2,630 | |
| Total liabilities and stockholders equity | 15,564 | 15,630 | 14,892 | 12,314 | 12,209 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 195 | 186 | 171 | 176 | 131 | |
| Deferred income taxes | 43 | 53 | −31 | −66 | −24 | |
| Share-based compensation | 47 | 116 | 115 | 103 | 72 | |
| Other, net | −3 | 8 | 2 | 8 | 33 | |
| Receivables | −145 | −78 | −778 | −95 | −415 | |
| Prepaid expenses and other current assets | 52 | −57 | −69 | −124 | −19 | |
| Medical claims and benefits payable | −132 | −40 | 580 | 153 | 471 | |
| Amounts due government agencies | −591 | −453 | 196 | −428 | 1,046 | |
| Accounts payable, accrued liabilities and other | −221 | 115 | 328 | 55 | 138 | |
| Deferred revenue | −51 | −367 | 59 | −11 | −5 | |
| Income taxes | −201 | −18 | −2 | 2 | 7 | |
| Net cash (used in) provided by operating activities | −535 | 644 | 1,662 | 773 | 2,119 | |
| Purchases of investments | −751 | −1,132 | −1,433 | −1,913 | −2,713 | |
| Proceeds from sales and maturities of investments | 1,408 | 1,111 | 772 | 1,398 | 1,329 | |
| Net cash paid in business combinations | −245 | −344 | −3 | −134 | −129 | |
| Purchases of property, equipment and capitalized software | −101 | −100 | −84 | −91 | −77 | |
| Other, net | 1 | 1 | 4 | −50 | −63 | |
| Net cash provided by (used in) investing activities | 312 | −464 | −744 | −790 | −1,653 | |
| Proceeds from borrowings under credit facility and term loans | 1,100 | 300 | 0 | — | — | |
| Repayment of credit facility and term loans | −1,100 | −300 | 0 | 0 | 0 | |
| Common stock purchases | −1,000 | −1,000 | 0 | −400 | −128 | |
| Proceeds from senior notes offerings, net of issuance costs | 838 | 740 | 0 | 0 | 740 | |
| Common stock withheld to settle employee tax obligations | −37 | −57 | −60 | −54 | −53 | |
| Other, net | 29 | −30 | 2 | 33 | 1 | |
| Net cash used in financing activities | −170 | −347 | −58 | −441 | −183 | |
| Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents | −393 | −167 | 860 | −458 | 283 | |
| Cash paid during the period for interest | 181 | 121 | 108 | 108 | 127 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is MOLINA HEALTHCARE, INC.'s CIK number?
MOLINA HEALTHCARE, INC.'s SEC CIK number is 0001179929 (1179929). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find MOLINA HEALTHCARE, INC.'s SEC filings?
All of MOLINA HEALTHCARE, INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did MOLINA HEALTHCARE, INC. last report earnings?
MOLINA HEALTHCARE, INC. (MOH) most recently filed an earnings 8-K with the SEC on Apr 22, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001179929-26-000020). This is MOLINA HEALTHCARE, INC.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is MOLINA HEALTHCARE, INC.'s most recent earnings 8-K?
MOLINA HEALTHCARE, INC.'s latest earnings 8-K (Item 2.02) was filed Apr 22, 2026 under accession 0001179929-26-000020. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View MOLINA HEALTHCARE, INC.'s latest earnings 8-K →
Look up any company's CIK number →